AI
Sunday, May 21, 2017 7:44:44 PM
AXSM – Receives Fast Track designation from the FDA for AXS-05 for the treatment of agitation in patients with Alzheimer’s disease.
And price does nothing...
May 9th Earnings report is a loss
...next...then BTIG Research initiates coverage with a price target of $14...current price is $4.10...and some other joker already had a $13 price target on AXSM...
I like the "news" section on this page:
https://stocknews.com/news/axsm-receives-fast-track-designation-from-the-fda-for-axs-05-for-80649094/
Is there a trade here...?... maybe...firm stop...$3.90...$3.80
And price does nothing...
May 9th Earnings report is a loss
...next...then BTIG Research initiates coverage with a price target of $14...current price is $4.10...and some other joker already had a $13 price target on AXSM...
I like the "news" section on this page:
https://stocknews.com/news/axsm-receives-fast-track-designation-from-the-fda-for-axs-05-for-80649094/
Is there a trade here...?... maybe...firm stop...$3.90...$3.80
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
